Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
921 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00073307 | Study of BAY43-9006 in Patients With Unresectable and/or Metastatic Renal Cell Cancer | completed | Phase 3 | 903 | BayerINDUSTRY | 19 | Feb 6, 2014 | clinicaltrials |
| NCT00989131 | Study of Paclitaxel in Patients With Ovarian Cancer | completed | Phase 3 | 789 | Oasmia Pharmaceutical ABINDUSTRY | 16 | Feb 4, 2014 | clinicaltrials |
| NCT00390806 |
| Oral HYCAMTIN Plus Whole Brain Radiation Therapy In Treatment Of Brain Metastases Resulting From Non-Small Lung Cancer |
| completed |
| Phase 3 |
| 472 |
| GlaxoSmithKlineINDUSTRY |
| 6 |
| Jan 20, 2014 |
| clinicaltrials |
| NCT00596830 | Carboplatin And Paclitaxel With Or Without CP-751, 871 (An IGF-1R Inhibitor) For Advanced NSCLC Of Squamous, Large Cell And Adenosquamous Carcinoma Histology | terminated | Phase 3 | 681 | PfizerINDUSTRY | 26 | Jan 13, 2014 | clinicaltrials |
| NCT00312208 | Docetaxel in Breast Cancer | completed | Phase 3 | 3,299 | SanofiINDUSTRY | 37 | Dec 30, 2013 | clinicaltrials |
| NCT00012389 | Irinotecan With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer | completed | Phase 3 | — | SanofiINDUSTRY | 7 | Dec 19, 2013 | clinicaltrials |
| NCT00058201 | Two Chemotherapy Regimens Compared With Observation in Treating Patients With Completely Resected Pancreatic Cancer | completed | Phase 3 | 1,030 | Royal Liverpool University HospitalOTHER_GOV | 13 | Dec 18, 2013 | clinicaltrials |
| NCT00721123 | A Long-term Extension Study of Tocilizumab (Myeloma Receptor Antibody [MRA]) in Patients With Rheumatoid Arthritis | completed | Phase 3 | 538 | Hoffmann-La RocheINDUSTRY | 17 | Nov 28, 2013 | clinicaltrials |
| NCT00474786 | Temsirolimus Versus Sorafenib As Second-Line Therapy In Patients With Advanced RCC Who Have Failed First-Line Sunitinib(INTORSECT) | completed | Phase 3 | 512 | PfizerINDUSTRY | 20 | Nov 21, 2013 | clinicaltrials |
| NCT00457392 | A Study In Patients With Non-Small Cell Lung Cancer To Test If Erlotinib Plus SU011248 Is Better Than Erlotinib Alone | completed | Phase 3 | 960 | PfizerINDUSTRY | 26 | Oct 29, 2013 | clinicaltrials |
| NCT00382031 | Zalutumumab in Patients With Non-curable Head and Neck Cancer | completed | Phase 3 | 286 | GenmabINDUSTRY | 12 | Oct 15, 2013 | clinicaltrials |
| NCT00003013 | Chemotherapy Plus Surgery in Treating Women With Breast Cancer | completed | Phase 3 | 450 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 11 | Sep 17, 2013 | clinicaltrials |
| NCT00043927 | Extensive Small Cell Lung Cancer Treatment Using An Investigational Drug Plus Chemotherapy In Chemotherapy-Naive Adults | completed | Phase 3 | 760 | GlaxoSmithKlineINDUSTRY | 34 | Aug 21, 2013 | clinicaltrials |
| NCT00045461 | Combination Chemotherapy With or Without Whole-Body Hyperthermia in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer | unknown | Phase 2 / Phase 3 | 241 | Ludwig-Maximilians - University of MunichOTHER | 3 | Aug 7, 2013 | clinicaltrials |
| NCT00673049 | Trial Of CP-751, 871 And Erlotinib In Refractory Lung Cancer(NSCLC) | terminated | Phase 3 | 583 | PfizerINDUSTRY | 27 | Jul 24, 2013 | clinicaltrials |
| NCT00014274 | Combination Chemotherapy in Treating Patients With Transitional Cell Cancer of the Urothelium | completed | Phase 2 / Phase 3 | 238 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 11 | Jun 12, 2013 | clinicaltrials |
| NCT00022191 | Cisplatin Plus Gemcitabine With or Without Paclitaxel in Treating Patients With Stage IV Urinary Tract Cancer | completed | Phase 3 | 608 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 16 | Jun 12, 2013 | clinicaltrials |
| NCT01555710 | Study of Palifosfamide-tris in Combination With Carboplatin and Etoposide in Chemotherapy Naïve Patients With Extensive-Stage Small Cell Lung Cancer (The MATISSE Study) | unknown | Phase 3 | 548 | Alaunos TherapeuticsINDUSTRY | 11 | May 21, 2013 | clinicaltrials |
| NCT00050973 | Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung Cancer | completed | Phase 3 | 623 | Eisai Inc.INDUSTRY | 11 | May 14, 2013 | clinicaltrials |
| NCT00083304 | Whole Brain Radiation Therapy With Oxygen, With or Without RSR13, in Women With Brain Metastases From Breast Cancer(ENRICH) | completed | Phase 3 | 368 | Spectrum Pharmaceuticals, IncINDUSTRY | 15 | May 10, 2013 | clinicaltrials |
| NCT00276276 | Active Symptom Control Alone Or In Combination With Oral Topotecan In Patients With Relapsed Resistant Small Cell Lung Cancer | completed | Phase 3 | 141 | GlaxoSmithKlineINDUSTRY | 6 | Apr 15, 2013 | clinicaltrials |
| NCT00002528 | Surgery With or Without Lymph Node Removal in Treating Older Women With Stage I or Stage IIA Breast Cancer(10-93) | completed | Phase 3 | 473 | ETOP IBCSG Partners FoundationNETWORK | 9 | Apr 4, 2013 | clinicaltrials |
| NCT00451958 | A Long-term Extension Study Evaluating a One-Month Dosing Regimen of Degarelix in Prostate Cancer Requiring Androgen Ablation Therapy | completed | Phase 3 | 386 | Ferring PharmaceuticalsINDUSTRY | 12 | Mar 21, 2013 | clinicaltrials |
| NCT00049998 | Oral Topotecan Versus Intravenous Docetaxel In Pretreated, Advanced Non-Small Cell Lung Cancer | completed | Phase 3 | 760 | GlaxoSmithKlineINDUSTRY | 31 | Mar 4, 2013 | clinicaltrials |
| NCT00694382 | Evaluation of AVE5026 in the Prevention of Venous Thromboembolism in Cancer Patients Undergoing Chemotherapy(SAVE-ONCO) | completed | Phase 3 | 3,212 | SanofiINDUSTRY | 49 | Jan 23, 2013 | clinicaltrials |
| NCT00327444 | Study of the Effect of Intravenous AVE0005 (VEGF Trap) in Advanced Ovarian Cancer Patients With Recurrent Symptomatic Malignant Ascites | completed | Phase 2 / Phase 3 | 58 | SanofiINDUSTRY | 9 | Jan 1, 2013 | clinicaltrials |
| NCT00295750 | The Efficacy and Safety of Degarelix One Month Dosing Regimens in Prostate Cancer | completed | Phase 3 | 620 | Ferring PharmaceuticalsINDUSTRY | 12 | Dec 19, 2012 | clinicaltrials |
| NCT00065468 | Study Evaluating Interferon And CCI-779 In Advanced Renal Cell Carcinoma(ARCC) | completed | Phase 3 | 626 | PfizerINDUSTRY | 25 | Oct 25, 2012 | clinicaltrials |
| NCT00003938 | Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients | completed | Phase 3 | 115 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 15 | Sep 24, 2012 | clinicaltrials |
| NCT00016211 | Radiation Therapy to Prevent Brain Metastases in Patients With Previously Treated Extensive-Stage Small Cell Lung Cancer | completed | Phase 3 | 287 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 12 | Sep 24, 2012 | clinicaltrials |
| NCT00017277 | Radiation Therapy With or Without Epoetin Alfa in Treating Patients With Head and Neck Cancer | terminated | Phase 3 | 47 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 10 | Sep 24, 2012 | clinicaltrials |
| NCT00053807 | Interleukin-2, Interferon Alfa, and Fluorouracil Compared With Observation in Treating Patients Who Have Undergone Surgery for Kidney Cancer | completed | Phase 3 | 96 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 8 | Sep 24, 2012 | clinicaltrials |
| NCT00064181 | Combination Chemotherapy With or Without Celecoxib in Treating Patients With Metastatic Colorectal Cancer | completed | Phase 3 | 86 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 5 | Sep 24, 2012 | clinicaltrials |
| NCT00617669 | A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) and Docetaxel in Metastatic Hormone Resistant Prostate Cancer(ENTHUSE M1C) | completed | Phase 3 | 1,494 | AstraZenecaINDUSTRY | 26 | Sep 10, 2012 | clinicaltrials |
| NCT00039000 | Study of Heat Shock Protein-Peptide Complex (HSPPC-96) Versus IL-2/DTIC for Stage IV Melanoma | completed | Phase 3 | 350 | Agenus Inc.INDUSTRY | 9 | Sep 7, 2012 | clinicaltrials |
| NCT00626548 | A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) in Non-metastatic Hormone Resistant Prostate Cancer(ENTHUSE M0) | terminated | Phase 3 | 2,577 | AstraZenecaINDUSTRY | 39 | Sep 3, 2012 | clinicaltrials |
| NCT00707304 | Safety and Efficacy of Talactoferrin in Previously Treated Patients With Non-small Cell Lung Cancer(FORTIS-M) | completed | Phase 3 | 742 | AgennixINDUSTRY | 23 | Aug 21, 2012 | clinicaltrials |
| NCT00069745 | Satraplatin in Hormone Refractory Prostate Cancer Patients Previously Treated With One Cytotoxic Chemotherapy Regimen | completed | Phase 3 | — | AgennixINDUSTRY | 15 | Aug 7, 2012 | clinicaltrials |
| NCT00393939 | Study Of Sunitinib In Combination With Docetaxel Vs Docetaxel In Patients With Advanced Breast Cancer(SUN 1064) | completed | Phase 3 | 594 | PfizerINDUSTRY | 27 | Jul 19, 2012 | clinicaltrials |
| NCT00471146 | Study Of Gemcitabine Plus AG-013736 Versus Gemcitabine For Advanced Pancreatic Cancer. | completed | Phase 3 | 630 | PfizerINDUSTRY | 24 | Jul 16, 2012 | clinicaltrials |
| NCT00002737 | Interferon Alfa With or Without Isotretinoin in Treating Patients With Metastatic Kidney Cancer | completed | Phase 3 | 320 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 9 | Jul 11, 2012 | clinicaltrials |
| NCT00002840 | Radiation Therapy With and Without Combination Chemotherapy in Patients With Resected Anaplastic Oligodendroglioma | completed | Phase 3 | 350 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 12 | Jul 10, 2012 | clinicaltrials |
| NCT00312845 | Study of VELCADE and Rituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma | completed | Phase 3 | 676 | Millennium Pharmaceuticals, Inc.INDUSTRY | 32 | Jun 25, 2012 | clinicaltrials |
| NCT00241449 | A Trial Comparing the Efficacy and Tolerability of Faslodex With Nolvadex in Postmenopausal Women With Advanced Breast Cancer | completed | Phase 3 | 51 | AstraZenecaINDUSTRY | 26 | Jun 6, 2012 | clinicaltrials |
| NCT00294437 | ZOMETA® (Zoledronic Acid) for Prevention of Bone Metastases | terminated | Phase 3 | 376 | Central European Cooperative Oncology GroupOTHER | 16 | May 1, 2012 | clinicaltrials |
| NCT00003643 | Combination Chemotherapy in Treating Men With Germ Cell Cancer | unknown | Phase 2 / Phase 3 | 498 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 14 | Mar 6, 2012 | clinicaltrials |
| NCT00003212 | Ifosfamide or Doxorubicin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma | completed | Phase 3 | 780 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 10 | Jan 20, 2012 | clinicaltrials |
| NCT00418574 | Efficacy Multicentre Trial of ImmunoTherapy Vaccination With Abagovomab to Treat Ovarian Cancer Patients(MIMOSA) | terminated | Phase 2 / Phase 3 | 888 | Menarini GroupINDUSTRY | 9 | Nov 24, 2011 | clinicaltrials |
| NCT00174655 | BIG 02/98 Docetaxel - Breast Cancer | completed | Phase 3 | 2,887 | SanofiINDUSTRY | 21 | Nov 10, 2011 | clinicaltrials |
Data updated 22 days agoSource updated unknownsource: clinicaltrials